Positron emission tomography/computed tomography in locally advanced breast cancer

Locally advanced breast cancer (LABC) is a relatively small group of breast cancer, but is significant because it carries a higher risk of locoregional recurrence and distant metastasis. The accepted approach for these patients is neoadjuvant chemotherapy before surgery as determining the response t...

Повний опис

Збережено в:
Бібліографічні деталі
Опубліковано в: :Experimental Oncology
Дата:2013
Автор: Ozkan, E.
Формат: Стаття
Мова:English
Опубліковано: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2013
Теми:
Онлайн доступ:https://nasplib.isofts.kiev.ua/handle/123456789/145235
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Цитувати:Positron emission tomography/computed tomography in locally advanced breast cancer / E. Ozkan // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 253-257. — Бібліогр.: 52 назв. — англ.

Репозитарії

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id nasplib_isofts_kiev_ua-123456789-145235
record_format dspace
spelling Ozkan, E.
2019-01-19T17:52:24Z
2019-01-19T17:52:24Z
2013
Positron emission tomography/computed tomography in locally advanced breast cancer / E. Ozkan // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 253-257. — Бібліогр.: 52 назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/145235
Locally advanced breast cancer (LABC) is a relatively small group of breast cancer, but is significant because it carries a higher risk of locoregional recurrence and distant metastasis. The accepted approach for these patients is neoadjuvant chemotherapy before surgery as determining the response to therapy in the early stages is of critical importance in respect of the approach taken to the disease. Positron emission tomography/computed tomography (PET/CT) using fluorine-18-fluorodeoxyglucose (18F-FDG) is currently used for staging, restaging and response monitoring in breast cancer. The areas of use of FDG PET/CT in LABC can be summarised as the evaluation of response to neoadjuvant chemotherapy in the early stage in particular, and the determination of unexpected areas of metastasis not detected by standard imaging techniques. There are current ongoing studies on promising new PET radiopharmaceuticals apart from FDG.
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Special issue on breast cancer
Positron emission tomography/computed tomography in locally advanced breast cancer
Article
published earlier
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
title Positron emission tomography/computed tomography in locally advanced breast cancer
spellingShingle Positron emission tomography/computed tomography in locally advanced breast cancer
Ozkan, E.
Special issue on breast cancer
title_short Positron emission tomography/computed tomography in locally advanced breast cancer
title_full Positron emission tomography/computed tomography in locally advanced breast cancer
title_fullStr Positron emission tomography/computed tomography in locally advanced breast cancer
title_full_unstemmed Positron emission tomography/computed tomography in locally advanced breast cancer
title_sort positron emission tomography/computed tomography in locally advanced breast cancer
author Ozkan, E.
author_facet Ozkan, E.
topic Special issue on breast cancer
topic_facet Special issue on breast cancer
publishDate 2013
language English
container_title Experimental Oncology
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
format Article
description Locally advanced breast cancer (LABC) is a relatively small group of breast cancer, but is significant because it carries a higher risk of locoregional recurrence and distant metastasis. The accepted approach for these patients is neoadjuvant chemotherapy before surgery as determining the response to therapy in the early stages is of critical importance in respect of the approach taken to the disease. Positron emission tomography/computed tomography (PET/CT) using fluorine-18-fluorodeoxyglucose (18F-FDG) is currently used for staging, restaging and response monitoring in breast cancer. The areas of use of FDG PET/CT in LABC can be summarised as the evaluation of response to neoadjuvant chemotherapy in the early stage in particular, and the determination of unexpected areas of metastasis not detected by standard imaging techniques. There are current ongoing studies on promising new PET radiopharmaceuticals apart from FDG.
issn 1812-9269
url https://nasplib.isofts.kiev.ua/handle/123456789/145235
citation_txt Positron emission tomography/computed tomography in locally advanced breast cancer / E. Ozkan // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 253-257. — Бібліогр.: 52 назв. — англ.
work_keys_str_mv AT ozkane positronemissiontomographycomputedtomographyinlocallyadvancedbreastcancer
first_indexed 2025-12-07T20:02:51Z
last_indexed 2025-12-07T20:02:51Z
_version_ 1850881103533965312